Le Lézard
Classified in: Tourism and vacations, Health, Covid-19 virus
Subject: SVY

UV Sanitizer Travel Wand Market Size Worth $209.9 Million By 2027: Grand View Research, Inc.


SAN FRANCISCO, Jan. 20, 2021 /PRNewswire/ --  The global UV sanitizer travel wand market size is anticipated to reach USD 209.9 million by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.6% from 2020 to 2027. The increasing rate of infectious diseases in hospitals, low power consumption, and ease of portability for cleaning small objects in the home and commercial spaces are major factors driving the product demand. Increasing usage of the product in order to prevent cross-contamination and reduce pathogens, bacteria, and germs on objects is acting as a major driver for the market.

Grand_View_Research_Logo

Key suggestions from the report:

Read 80 page research report with ToC on "UV Sanitizer Travel Wand Market Size, Share & Trends Analysis Report By Application (Residential, Commercial), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/uv-sanitizer-travel-wand-market

Companies in the market are focusing on gaining market share by increasing expenditure on advertising via social media and introducing new products in the market. For instance, in June 2020, Spark Innovation LLC launched a new UV travel wand with a light wavelength of 240-280nm and is certified by FCC, CE, and RoSH. Additionally, to save power and improve safety, the travel wand has a smart auto timing off in 180 seconds and an extra thoughtful Child lock to avoid kids' misuse. This factor is acting as a major driver for the market.

The recent outbreak of coronavirus disease (Covid-19) is estimated to increase the adoption of UV sanitizer travel wand among consumers. In terms of application, the residential segment held the largest share in 2019 and is estimated to be the fastest-growing segment from 2020 to 2027. Rising awareness among consumers pertaining to a number of infectious bacteria present on the daily used objects is acting as a major driver for increasing the adoption of UV sanitizer travel wand. The commercial segment is estimated to witness growth in the coming years owing to rising demand from the healthcare sector. As per Shenzhen UVLED Optical Technology Co. Ltd., from January to February 2020, the company's brand 59S has sold over 8000 units per day and 1000+ hospitals were using the company's brand 59S UV travel wand owing to the recent outbreak of Covid-19 in China.

The offline distribution channel dominated the market with a revenue-based share of 69.3% in 2019. Brick and mortar is the most preferred distribution channel due to their provision of detailed instructions about usability by the product specialists. Many consumers in the market prefer purchasing from the stores to find the right fit as per their convenience and get the right product as per their needs.

North America dominated the market with a revenue-based share of 40.5% in 2019. Demand in the region is high as consumers in the region are more aware and willing to spend on innovative and value-added products. Mature and higher expenditure power of the healthcare sector in this region is resulting in increasing adoption of products to reduce the number of hospital infectious diseases.

Grand View Research has segmented the global UV sanitizer travel wand market based on application, distribution channel, and region:

List of Key Players of UV Sanitizer Travel Wand Market

Find more research reports on Electronic & Electrical Industry, by Grand View Research:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected] 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg


These press releases may also interest you

at 10:21
Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net loss improved to RMB208.8 million, representing a significant turnaround from a negative...

at 10:17
The life insurance comparison site QuickQuote.com recently published a guide to accidental death and dismemberment (AD&D) insurance. It revealed that some plans cost only $4 a month and provide $100,000 in coverage....

at 10:15
Options Medical Weight Losstm, the nation's premier medical weight loss clinic and provider of medical weight loss solutions, is proud to announce its second clinic in the Metro Atlanta area at 3651 Peachtree Parkway, Suite B. The clinic cordially...

at 10:15
The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global MRSA drugs market size reached US$ 3.8...

at 10:15
Chartis, a comprehensive healthcare advisory firm, today announced that its line of business focused on helping medical staff services departments (MSSDs) transform to elevate performance will restore its former name?Greeley, A Chartis Company. It...

at 10:10
Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, released annual...



News published on and distributed by: